Vanguard Group’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$20.3M Sell
931,305
-77,072
-8% -$1.6M ﹤0.01% 2615
2025
Q3
$21.6M Sell
1,008,377
-35,236
-3% -$790K ﹤0.01% 2583
2025
Q2
$26.8M Sell
1,043,613
-6,409
-0.6% -$188K ﹤0.01% 2418
2025
Q1
$38.4M Buy
1,050,022
+15,043
+1% +$517K ﹤0.01% 2210
2024
Q4
$31.7M Buy
1,034,979
+34,836
+3% +$1.16M ﹤0.01% 2363
2024
Q3
$37.7M Buy
1,000,143
+161,597
+19% +$6.23M ﹤0.01% 2300
2024
Q2
$33.2M Sell
838,546
-37,469
-4% -$1.21M ﹤0.01% 2316
2024
Q1
$29.4M Buy
876,015
+8,020
+0.9% +$270K ﹤0.01% 2408
2023
Q4
$28.9M Buy
867,995
+36,675
+4% +$1.18M ﹤0.01% 2430
2023
Q3
$26.1M Buy
831,320
+11,678
+1% +$367K ﹤0.01% 2443
2023
Q2
$26M Buy
819,642
+15,470
+2% +$500K ﹤0.01% 2478
2023
Q1
$26.6M Buy
804,172
+3,542
+0.4% +$116K ﹤0.01% 2462
2022
Q4
$25.8M Buy
800,630
+9,769
+1% +$333K ﹤0.01% 2507
2022
Q3
$28.2M Buy
790,861
+49,341
+7% +$2.05M ﹤0.01% 2474
2022
Q2
$30.5M Buy
741,520
+18,234
+3% +$886K ﹤0.01% 2432
2022
Q1
$41.9M Buy
723,286
+7,958
+1% +$435K ﹤0.01% 2394
2021
Q4
$42M Buy
715,328
+35,531
+5% +$2.16M ﹤0.01% 2455
2021
Q3
$41.3M Buy
679,797
+65,201
+11% +$3.82M ﹤0.01% 2464
2021
Q2
$36.9M Sell
614,596
-19,193
-3% -$962K ﹤0.01% 2529
2021
Q1
$29.9M Buy
633,789
+8,459
+1% +$348K ﹤0.01% 2591
2020
Q4
$23.5M Buy
625,330
+12,599
+2% +$415K ﹤0.01% 2556
2020
Q3
$20M Sell
612,731
-26,540
-4% -$1.12M ﹤0.01% 2459
2020
Q2
$29M Buy
639,271
+2,462
+0.4% +$126K ﹤0.01% 2254
2020
Q1
$29.1M Buy
636,809
+2,055
+0.3% +$93K ﹤0.01% 2111
2019
Q4
$27.4M Sell
634,754
-101,885
-14% -$4.15M ﹤0.01% 2384
2019
Q3
$26.7M Buy
736,639
+113,743
+18% +$4.79M ﹤0.01% 2336
2019
Q2
$29.3M Buy
622,896
+68,236
+12% +$2.88M ﹤0.01% 2349
2019
Q1
$19.5M Sell
554,660
-181,674
-25% -$7.14M ﹤0.01% 2517
2018
Q4
$27.5M Buy
736,334
+58,659
+9% +$2.29M ﹤0.01% 2298
2018
Q3
$23M Sell
677,675
-104,846
-13% -$3.07M ﹤0.01% 2515
2018
Q2
$19.5M Sell
782,521
-464,116
-37% -$12.9M ﹤0.01% 2572
2018
Q1
$37.2M Sell
1,246,637
-8,850
-0.7% -$296K ﹤0.01% 2220
2017
Q4
$40.3M Sell
1,255,487
-249,429
-17% -$8.03M ﹤0.01% 2172
2017
Q3
$44.8M Buy
1,504,916
+80,142
+6% +$2.19M ﹤0.01% 2088
2017
Q2
$33.2M Sell
1,424,774
-1,719
-0.1% -$39.9K ﹤0.01% 2227
2017
Q1
$31.2M Buy
1,426,493
+166,050
+13% +$3.75M ﹤0.01% 2224
2016
Q4
$28.4M Sell
1,260,443
-25,223
-2% -$609K ﹤0.01% 2248
2016
Q3
$29.4M Buy
1,285,666
+161,605
+14% +$3.61M ﹤0.01% 2183
2016
Q2
$24M Buy
1,124,061
+49,857
+5% +$1.57M ﹤0.01% 2248
2016
Q1
$36.9M Buy
1,074,204
+431,436
+67% +$11.4M ﹤0.01% 2001
2015
Q4
$17.7M Buy
642,768
+257,508
+67% +$7.04M ﹤0.01% 2353
2015
Q3
$11.5M Buy
385,260
+31,848
+9% +$1.04M ﹤0.01% 2538
2015
Q2
$14.9M Buy
353,412
+333,613
+1,685% +$15.8M ﹤0.01% 2482
2015
Q1
$990K Buy
+19,799
New +$962K ﹤0.01% 3633

Other funds holding ATEX

Vanguard Group's ATEX Position: Q4 2025 in Review

Vanguard Group reduced its Anterix (ATEX) stake by 7.6% in Q4 2025, selling an estimated $1.6M and leaving 931,305 shares worth $20.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Vanguard Group first reported a position in ATEX in Q1 2015 and has held it in 44 quarters since. The position peaked at $44.8M in Q3 2017. 117 funds tracked by Wall St. Rank hold ATEX as of Q4 2025.

  • Vanguard Group held 931,305 shares of Anterix worth $20.3M as of Q4 2025.
  • Vanguard Group sold 77,072 Anterix shares in Q4 2025, an estimated $1.6M.
  • Anterix made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2615 holding.
  • Vanguard Group first reported a position in Anterix in Q1 2015 and has held it in 44 quarters since.
  • Vanguard Group's Anterix position peaked at $44.8M in Q3 2017.
  • 117 funds tracked by Wall St. Rank held Anterix as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.